A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI
Phase 2
Completed
- Conditions
- Rash Due to Epidermal Growth Factor Receptor Inhibitors
- Interventions
- Drug: RECONVAL CREAMDrug: PLACEBO
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 18
- Registration Number
- NCT01763307
A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients
Phase 4
- Conditions
- Neuromuscular Blockade
- Interventions
- Drug: Atropine/Neostigmine
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2013-09-10
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 130
- Registration Number
- NCT01761552
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Brief Internet Based Treatment for PTSD
Not Applicable
- Conditions
- PTSD
- Interventions
- Other: CBT delivered via Internet
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2013-05-23
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 900
- Registration Number
- NCT01760213
- Locations
- 🇮🇱
Hadassah medical organization, Jerusalem, Israel
Outcomes of Delivery in Patients With Dyspareunia
Completed
- Conditions
- Provoked VestibulodyniaPregnancyPelvic Floor DysfunctionDyspareunia
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2016-10-11
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 173
- Registration Number
- NCT01753258
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Longitudinal Follow-up After C1 Implant Stabilization Values
Not Applicable
Completed
- Conditions
- Jaw, Edentulous, Partially
- Interventions
- Drug: C1 Implant
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 10
- Registration Number
- NCT01746160
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
TSO in Pediatric Autistic Spectrum Disorders
- First Posted Date
- 2012-11-28
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 9
- Registration Number
- NCT01734941
- Locations
- 🇮🇱
The Neuro-Cognitive Center, Pediatric Division, Hadassah-Hebrew University Medical Center, Jerusalem, Mount Scopus, Israel
Safety of the Automatic Respiration Transfer System- Timer
Not Applicable
- Conditions
- Intensive Care Patients on a Ventilator
- First Posted Date
- 2012-11-28
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 20
- Registration Number
- NCT01735292
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Vaginal DHEA for Women After Breast Cancer
Phase 2
Withdrawn
- Conditions
- Vaginal DrynessBreast CancerUrinary IncontinenceQuality of LifeSexual Satisfaction
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-11-09
- Last Posted Date
- 2017-11-28
- Lead Sponsor
- Hadassah Medical Organization
- Registration Number
- NCT01724242
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Optimal Time for Staple/Dressing Removal
Completed
- Conditions
- Patient SatisfactionSurgical Wound HealingSurgical Wound Infection
- Interventions
- Other: questionnaire
- First Posted Date
- 2012-11-09
- Last Posted Date
- 2015-07-28
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 1500
- Registration Number
- NCT01724255
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).
- Conditions
- Lung CancerPancreatic Cancer
- Interventions
- Other: C11-Erlotinib PET/CT
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2012-10-30
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 30
- Registration Number
- NCT01717807
- Locations
- 🇮🇱
Hadassah Hebrew University Medical Center, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath